SCHEMBL2299764

SCHEMBL2299764

c1ccc2c(c1)cnc1c3cnncc3ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.48
GPR3 P46089 1/20 0.48
HPRT1 P00492 3/20 0.43
ALDH1A1 P00352 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
HSD17B10 Q99714 2/20 0.41
CYP2A6 P11509 2/20 0.41
TSHR P16473 1/20 0.41
CYP3A4 P08684 4/20 0.38
LMNA P02545 3/20 0.38
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
CYP1A2 P05177 3/20 0.38
PMP22 Q01453 2/20 0.38
TP53 P04637 2/20 0.38
GOT1 P17174 2/20 0.38
MAOA P21397 2/20 0.38
APEX1 P27695 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30956235 0.86 HPRT1 (0.61) KDM4EGPR3HPRT1ALDH1A1TDP1
SCHEMBL241747 0.86 HPRT1 (0.54) KDM4EGPR3HPRT1ALDH1A1TDP1
Hydrochloric Acid SCHEMBL3322796 0.84 HPRT1 (0.52) KDM4EGPR3HPRT1ALDH1A1TDP1
SCHEMBL19748987 0.83 KDM4E (0.60) KDM4EGPR3HPRT1ALDH1A1TDP1
SCHEMBL14150966 0.80 CLK1 (0.51) KDM4EGPR3HPRT1ALDH1A1TDP1
SCHEMBL22045540 0.79 HPRT1 (0.64) KDM4EGPR3HPRT1ALDH1A1TDP1
SCHEMBL29350993 0.79 ALDH1A1 (0.60) KDM4EGPR3HPRT1ALDH1A1TDP1
SCHEMBL2407872 0.79 ALDH1A1 (0.60) KDM4EGPR3HPRT1ALDH1A1TDP1
SCHEMBL14150896 0.78 KDM4E (0.46) KDM4EGPR3HPRT1ALDH1A1TDP1
Perchlorate SCHEMBL3915498 0.77 KDM4E (0.44) KDM4EGPR3HPRT1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536683-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY AROMATIC NUCLEOPHILIC SUBSTITUTION Centre National De La Recherche Scientifique (FR) 2012-12-26 EP claimed
US-20120316337-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP UNIVERSITE DU MAINE (FR) 2012-12-13 US claimed
WO-2011101599-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY AROMATIC NUCLEOPHILIC SUBSTITUTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2011-08-25 WO claimed
US-20120316337-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP UNIVERSITE DU MAINE (FR) 2012-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120316337-A1 METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP COMT, NAA15, NUDC KDM4E 847/4885GPR3 3228/4885HPRT1 3060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.